Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the
Descrição
OPDIVO® (nivolumab) + YERVOY® (ipilimumab) Efficacy in Metastatic Melanoma
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada, BMC Cancer
Frontiers Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity, Journal for ImmunoTherapy of Cancer
Frontiers Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan
PDF] Combined Nivolumab and Ipilimumab or Monotherapy in Previously Untreated Melanoma
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity, Journal for ImmunoTherapy of Cancer
Nivolumab in Combination With Ipilimumab in BRAF V600 Wild-Type Unresectable or Metastatic Melanoma - The ASCO Post
The forgotten role of adjuvant immune checkpoint inhibitors in preventing melanoma brain metastasis
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
de
por adulto (o preço varia de acordo com o tamanho do grupo)
_20140516.jpg)
